Joachim Frost

Author information from the last article

E-post: joachim.frost@stolav.no

Avdeling for klinisk farmakologi

St. Olavs hospital

Avdeling for laboratoriemedisin

Vestre Viken

Institutt for klinisk og molekylær medisin

NTNU

Joachim Frost er ph.d., spesialist i klinisk farmakologi, overlege og førsteamanuensis.

Articles by Joachim Frost

How dangerous is MDMA?

Joachim Frost

25.05.2022: Use of MDMA seems to be increasing in Norway. But how dangerous is the drug really? The Journal of the Norwegian Medical Association is now publishing a study by Jamt et al. in which an increase has been observed in the number of cases with findings of 3,4-methylenedioxymethamphetamine (MDMA) in...

Quetiapine is not a sleeping pill

Karen Astrid Boldingh Debernard,
Joachim Frost,
Pål-Didrik Hoff Roland

16.09.2019: Use of the antipsychotic drug quetiapine to treat sleep disorders has become widespread, also in Norway. Its efficacy is poorly documented, and even low doses may have substantial side effects. There is thus reason to warn against prescribing quetiapine for sleep. Quetiapine is a second-generation...

Immediate telephonic alerting of deviating pharmacological test results

Trond Trætteberg Serkland,
Ilah Le Nygaard,
Elena Kvan,
Joachim Frost,
Lena Aronsen,
Sigrid Narum,
Tormod Bjånes

01.11.2018: An overview is now available of instances where laboratories should immediately alert clinicians to deviating pharmacological test results when the patient's life and health may be at risk. In certain cases when analyses of drugs or other foreign substances such as methanol are requisitioned, the...